CVS Caremark seeking a possible $200 copay for Wegovy and Zepbound
Although $200 is a steep monthly co-pay for a covered brand-name medication, it’s still significantly lower than the $500 price Novo Nordisk charges through its direct-to-consumer platform for uninsured individuals.